Role of the primary care physician in problems of substance abuse

Archives of Internal Medicine

Volumn 159, Issue 9, 1999, Pages 913-924

  Weaver, Michael F ^a   Jarvis, Margaret A E ^b   Schnoll, Sidney H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Marworth   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMOBARBITAL; BUTALBITAL; BUTORPHANOL; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; ESTAZOLAM; ETHCHLORVYNOL; FENTANYL; FLUMAZENIL; FLURAZEPAM; GLUTETHIMIDE; HALAZEPAM; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MEPROBAMATE; METHYPRYLON; MORPHINE; NALBUPHINE; OPIATE; OXAZEPAM; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PENTOBARBITAL; PETHIDINE; PHENOBARBITAL; PRAZEPAM; PSYCHEDELIC AGENT; QUAZEPAM; SECBUTABARBITAL; SECOBARBITAL; SUFENTANIL; TEMAZEPAM; TRIAZOLAM; UNINDEXED DRUG;

DRUG DEPENDENCE TREATMENT; EMPATHY; HUMAN; HUMAN TISSUE; LONG TERM CARE; METHADONE TREATMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE;

ACUTE DISEASE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HALLUCINOGENS; HUMANS; HYPNOTICS AND SEDATIVES; OPIOID-RELATED DISORDERS; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 0033542033     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.9.913     Document Type: Review

References (47)

1. Kissen B. Medical management of alcoholic patients. In: Kissen B, Begleiter H, eds. Treatment and Rehabilitation of the Chronic Alcoholic. New York, NY: Plenum Publishing Co; 1997.
2. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J. 1995;94:135-140.
3. Buchsbaum DG, Buchanan RG, Centor RM, Schnoll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115:774-777.
4. Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med. 1984;101:847-851.
5. Monteiro MG, Pires MLN, Masur J. The trauma questionnaire for detecting alcohol abuse: limiting factors. Alcohol. 1986;3:287-289.
6. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston, Mass: Little Brown & Co Inc; 1970.
7. Glassroth J, Adam GD, Schnoll SH. The impact of substance abuse on the respiratory system. Chest. 1987;91:596-602.
8. White NJ, Chanthavanich P, Krishna S, Bunch C, Silamut K. Quinine disposition kinetics. Br J Clin Pharmacol. 1983;16:399-403.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
10. Weissman DE, Haddox JD. Qpioid pseudoaddiction: an iatrogenic syndrome. Pain. 1989;36:363-366.
11. Schnoll SH, Finch J. Medical education for pain and addiction: making progress toward answering a need. J Law Med Ethics. 1994;22:252-256.
12. Gold MS, Redmond DE, Kleber HD. Clonidine in opiate withdrawal. Lancet. 1978;1:929-930.
13. Loimer N, Hofmann P, Chaudhry H. Ultrashort non-invasive opiate detoxification. Am J Psychiatry. 1993;150:5.
14. Loimer N, Linzmayer L, Grunberger J. Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. Drug Alcohol Depend. 1991;28:265-268.
15. Loimer N, Linzmayer L, Schmid R, Grunberger J. Similar efficacy of abrupt and gradual opiate detoxification. Am J Drug Alcohol Abuse. 1991;17: 307-312.
16. Loimer N, Schmid R, Lenz K, Presslich O, Grunberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitate. Br J Psychiatry. 1990;157:748-752.
17. Arena JM, Drew RH. Poisoning: Toxicology, Symptoms, Treatments. 5th ed. Springfield, III: Charles C Thomas Publisher; 1986.
18. Seyffart G. Antihistamines and other sedatives. In: Haddad LM, Winchester JF, eds. Clinical Management of Poisoning and Drug Overdose. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1990: 839-850.
19. Lheureux P, Vranckx M, Leduc D, Askenasi R. Flumazenil in mixed benzodiazepine/tricyclic antidepressant overdose: a placebo-controlled study in the dog. Am J Emerg Med. 1992;10: 184-188.
20. Lovejoy FH Jr, Linden CH. Acute poison and drug overdosage. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Book Co; 1994:2441-2461.
21. Smith DE, Wesson DR. Phenobarbital technique for treatment of barbiturate dependence. Arch Gen Psychiatry. 1971;24:56-60.
22. Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DO, Calkins DO. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994;272: 519-523.
23. Cushman P Jr. Delirium tremens: update on an old disorder. Postgrad Med. 1987;82:117-122.
24. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and post traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol. 1992;12(suppl 1):36S-41S.
25. Higgit A, Fonagy P, Toone B, Shine P. The prolonged benzodiazepine withdrawal syndrome: anxiety or hysteria? Acta Psychiatr Scand. 1990;82:165-168.
26. Wilkerson RD. Cardiovascular toxicity of cocaine. NIDA Res Monogr. 1988;88:304-324.
27. Nademanee K, Gorelick DA, Josephson MA, et al. Myocardial ischemia during cocaine withdrawal. Ann Intern Med. 1989;111:876-880.
28. Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J. 1988;115:1068-1076.
29. Karan LD, Haller DL, Schnoll SH, Cocaine. In: Frances RJ, Miller SI, eds. Clinical Textbook of Addictive Disorders. New York, NY: Guilford Press; 1991:121-145.
30. Satel SL, Price LH, Palumbo JM, et al. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective study. Am J Psychiatry. 1991; 148:1712-1716.
31. Schnoll SH. Street PCP scene: issues on synthesis and contamination. J Psychedelic Drugs. 1980; 12:229.
32. Daghestani AN, Schnoll SH. Phencyclidine abuse and dependence. In: American Psychiatric Association: Treatments of Psychiatric Disorders. Washington, DC: American Psychiatric Association; 1989:1209-1218.
33. Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Human Toxicol. 1989;8:287-292.
34. Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol. 1989;8:293-300.
35. Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile substance abuse. Hum Toxicol. 1989;8:301-306.
36. Parker JO. Clinical, circulatory, and hematologic effects of isobutyl nitrite. In: Isobutyl Nitrite and Related Compounds. San Francisco, Calif: Pharmex Limited; 1979:70-78.
37. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: The Guilford Press; 1991.
38. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88:315-336.
39. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
40. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
41. Hoffmann G, Halikas JA, Mee-Lee D, Weedman RD. Patient Placement Criteria for the Treatment of Psychoactive Substance Use Disorders. Washington, DC: American Society of Addiction Medicine; 1991.
42. Rettig RA, Yarmolinski A, eds, for the Committee on Federal Regulation of Methadone Treatment, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995.
43. Hoffmann NG, Miller NS. Treatment outcomes for abstinence-based programs. Psychiatr Ann. 1992; 22:402-408.
44. Drug Facts and Comparisons. St Louis, Mo: Facts and Comparisons Inc; 1995.
45. Galanter M, Kleber HD, eds. Textbook of Substance Abuse Treatment. Washington, DC: American Psychiatric Press; 1994.
46. Gilman AG, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. New York, NY: Pergamon Press; 1990.
47. Physician's Desk Reference. Montvale, NJ: Medical Economics Data Production Co; 1994.